Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer

International Journal of Pharmaceutics

Volumn 353, Issue 1-2, 2008, Pages 233-242

  Paolino, Donatella ^a   Cosco, Donato ^a   Muzzalupo, Rita ^b   Trapasso, Elena ^a   Picci, Nevio ^b   Fresta, Massimo ^a  

^a University Magna Græcia of Catanzaro   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

5 Fluorouracil; Bola surfactant; Cell cytotoxicity; Niosomes; Percutaneous permeation

Indexed keywords

ALPHA,OMEGA HEXADECYL BIS (1 AZA 18 CROWN 6); CHOLESTEROL; CROWN ETHER DERIVATIVE; FLUOROURACIL; NIOSOME; PROTEIN P53; SORBITAN OLEATE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CONFOCAL LASER MICROSCOPY; DISPERSION; DRUG CYTOTOXICITY; DRUG MIXTURE; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN FOLDING; SKIN CANCER; STRATUM CORNEUM; TUMOR SUPPRESSOR GENE; ULTRASOUND;

EID: 40149107853     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.11.037     Document Type: Article

References (39)

1. A. Balasubramaniam V.A. Kumar K.S. Pillai Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride Drug Dev. Ind. Pharm. 28 2002 1181 1193
2. R.R. Boinpally S.L. Zhou S. Poondru G. Devraj B.R. Jasti Lecithin vesicles for topical delivery of diclofenac Eur. J. Pharm. Biopharm. 56 2003 389 392
3. P. Boukamp S. Popp K. Bleuel E. Tomakidi A. Burkle N.E. Fusenig Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature Oncogene 18 1999 5638 5645
4. J.A. Bouwstra D.A. van Hal H.E. Hofland H.E. Junginger Preparation and characterization of nonionic surfactant vesicles Colloids Surf. A 123 1997 71 80
5. G.M. El Maghraby A.C. Williams B.W. Barry Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes Int. J. Pharm. 276 2004 143 161
6. J.Y. Fang C.T. Hong W.T. Chiu Y.Y. Wang Effect of liposomes and niosomes on skin permeation of enoxacin Int. J. Pharm. 219 2001 61 72
7. Z. Fiume Final report on the safety assessment of Lecithin and Hydrogenated Lecithin Int. J. Toxicol. 20 2001 21 45
8. M. Fresta G. Puglisi Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles J. Drug Target. 4 1996 95 101
9. M. Fresta A. Villari G. Puglisi G. Cavallaro 5-Fluorouracil various kinds of loaded liposomes: encapsulation efficiency, storage stability and fusogenic properties Int. J. Pharm. 99 1993 145 156
10. K. Gross L. Kircik G. Kricorian 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction Dermatol. Surg. 33 2007 433 440
11. R.R. Gupta S.K. Jain M. Varshney AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil Colloids Surf. B: Biointerfaces 41 2005 25 32
12. Y. Hao F. Zhao N. Li Y. Yang K. Li Studies on a high encapsulation of colchicine by a niosome system Int. J. Pharm. 244 2002 73 80
13. C.P. Jain S.P. Vyas Preparation and characterization of niosomes containing rifampicin for lung targeting J. Microencapsul. 12 1995 401 407
14. J.L. Jorizzo P.S. Carney W.T. Ko P. Robins S.H. Weinkle W.P. Werschler Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule Cutis 74 2004 18 23
15. A.M. Kligman E. Christophers Preparation of isolated sheets of human skin Arch. Dermatol. 88 1963 702 705
16. S.B. Kulkarni G.V. Betageri M. Singh Factors affecting microencapsulation of drugs in liposomes J. Microencapsul. 12 1995 229 246
17. T.A. Lehman R. Modali P. Boukamp J. Stanek W.P. Bennett J.A. Welsh R.A. Metcalf M.R. Stampfer N. Fusenig E.M. Rogan p53 mutations in human immortalized epithelial cell lines Carcinogenesis 14 1993 833 839
18. M. Manconi C. Sinico D. Valenti F. Lai A.M. Fadda Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin Int. J. Pharm. 311 2006 11 19
19. S.T. McGillis H. Fein Topical treatment strategies for non-melanoma skin cancer and precursor lesions Semin. Cutan. Med. Surg. 23 2004 174 183
20. F.M. Menger J.S. Keiper Gemini surfactants Angew. Chem. Int. Ed. Engl. 39 2000 1906 1920
21. L.G. Morse C. Kendrick D. Hooper H. Ward E. Parry Treatment of squamous cell carcinoma with intralesional 5-fluorouracil Dermatol. Surg. 29 2003 1150 1153
22. R. Muzzalupo G.A. Ranieri C. La Mesa Translational diffusion and other physicochemical properties of a bolaform surfactant in solution Langmuir 12 1996 3157 3161
23. R. Muzzalupo S. Trombino F. Iemma F. Puoci C. La Mesa N. Picci Preparation and characterization of bolaform surfactant vesicles Colloids Surf. B: Biointerfaces 46 2005 78 83
24. B. Nasseri Effect of cholesterol and temperature on the elastic properties of niosomal membranes Int. J. Pharm. 300 2005 95 101
25. T.H. Nguyen D.Q. Ho Nonmelanoma skin cancer Curr. Treat. Options Oncol. 3 2002 193 203
26. D. Paolino G. Lucania D. Mardente F. Alhaique M. Fresta Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers J. Control. Rel. 106 2005 99 110
27. D. Paolino P. Sinha M. Fresta M. Ferrari Drug delivery systems J.G. Webster The Encyclopedia of Medical Devices and Instrumentations 2nd ed. 2006 John Wiley & Sons 437 495
28. D. Paolino R. Muzzalupo A. Ricciardi C. Celia N. Picci M. Fresta In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery Biomed. Microdevices 9 2007 421 433
29. A. Pardakhty J. Varshosaz A. Rouholamini In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin Int. J. Pharm. 328 2007 130 141
30. R.F. Ryan E.T. Krementz M.S. Litwin A role for topical 5-fluorouracil therapy in melanoma J. Surg. Oncol. 38 1988 250 256
31. P. Saarinen-Savolainen T. Jarvinen H. Taipale A. Urtti Method for evaluating drug release from liposomes in sink conditions Int. J. Pharm. 159 1997 27 33
32. A. Saija A. Tomaino D. Trombetta A. De Pasquale N. Uccella T. Barbuzzi D. Paolino F. Bonina In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents Int. J. Pharm. 199 2000 39 47
33. A. Shahiwala A. Misra Studies in topical application of niosomally entrapped nimesulide J. Pharm. Pharm. Sci. 5 2002 220 225
34. B.N. Singh R.B. Singh J. Singh Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum Int. J. Pharm. 298 2005 98 107
35. E. Stockfleth W. Sterry New treatment modalities for basal cell carcinoma Recent Results Cancer Res. 160 2002 259 268
36. E. Touitou N. Dayan L. Bergelson B. Godin M. Eliaz Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties J. Control. Rel. 65 2000 403 418
37. I.F. Uchegbu P.S. Vyas Non-ionic surfactant based vesicles (niosomes) in drug delivery Int. J. Pharm. 172 1998 33 70
38. S. van Ruth F.G. Jansman C.J. Sanders Total body topical 5-fluorouracil for extensive non-melanoma skin cancer Pharm. World Sci. 28 2006 159 162
39. S.P. Vyas R.P. Singh S. Jain V. Mishra S. Mahor P. Singh P.N. Gupta A. Rawat P. Dubey Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B Int. J. Pharm. 296 2005 80 86